Get the Stockscreener App
0.00
100.00%
-0.048
Io Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.048
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.45M
Revenue:
-
Net Income/Loss:
$-88.35M
P/E Ratio:
0.00
EPS:
-1.3391
Net Cash Flow:
$-81.07M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.00 | 3.45M | 0 | -88.35M | -81.07M | -1.3391 |
VRTX
Vertex Pharmaceuticals Inc
|
440.90 | 114.99B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
697.39 | 75.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.01 | 49.92B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.25 | 38.92B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
143.44 | 31.88B | 742.00K | -1.37B | -1.07B | -7.0731 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-08-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-30-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-30-25 | Downgrade | TD Cowen | Buy → Hold |
Io Biotech Inc Stock (IOBT) Latest News
IO Biotech (IOBT) Stock Price, News & Analysis $IOBT - MarketBeat
IO Biotech, Inc. (IOBTQ) Shareholders Equity (Quarterly) - Zacks Investment Research
TradingKey - TradingKey
IO Biotech, Inc. (IOBTQ) Book Value - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Enterprise Value - Zacks Investment Research
Zacks.com - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Revenue (Quarterly) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Eps Diluted - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Total Assets (Quarterly) - Zacks Investment Research
Layoff Tracker: Gilead laying off vast majority of Arcellx employees - BioSpace
Fierce Biotech Layoff Tracker 2026: Autolus decreases headcount by 13%; Replimune reduces staff - Fierce Biotech
$IO Biotech (IOBTQ.US)$ - Moomoo
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine - MSN
IOBT IO Biotech reports 60 percent narrower Q3 2025 loss than estimates, shares remain unchanged.Expert Momentum Signals - Cổng thông tin điện tử Tỉnh Sơn La
IO Biotech Inc (IOBTQ) Stock Price, Quote, News & History - Benzinga
IOBTQ: IO Biotech, Inc.Interactive Chart - Zacks Investment Research
What is the current Price Target and Forecast for IO Biotech, Inc. (IOBTQ) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Dividend Yield (TTM) - Zacks Investment Research
What is the long term forecast for IO Biotech Inc stock2026 Retail & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
IO Biotech, Inc. (IOBTQ) Net Income (TTM) - Zacks Investment Research
Why are shares of IO Biotech plummeting? - MSN
Finance Watch: Replimune Cutting Jobs As FDA Rejects RP1 A Second Time - Citeline News & Insights
IO Biotech, Inc. (IOBTQ) Pe Ratio (TTM) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Options Chain - Yahoo! Finance Canada
IO Biotech, Inc. (IOBTQ) Cash From Operations (TTM) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Market Cap - Zacks Investment Research
Dividend HistoryIO Biotech, Inc. (IOBTQ) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Ps Ratio (TTM) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Peg Ratio (TTM) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Earnings Yield (TTM) - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Debt Equity Ratio (Quarterly) - Zacks Investment Research
All News for IOBTQ : IO Biotech, Inc. - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) BetaZacks.com - Zacks Investment Research
IO Biotech, Inc. (IOBTQ) Dividend (TTM) - Zacks Investment Research
Meet The Attorneys Guiding IO Biotech In Ch. 7 - Law360
IO Biotech, Inc. (IOBTQ) Return On Equity (TTM) - Zacks Investment Research
What date does IO Biotech, Inc.'s (IOBTQ) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
IOBTQ : Io Biotech, Inc. Key Company Details - Zacks Investment Research
Should I buy IO Biotech, Inc. (IOBTQ) - Zacks Investment Research
IOBTQ : IO Biotech, Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
Return on assets % of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Total common shares outstanding of IO Biotech, Inc. – OTC:IOBTQ - TradingView
Enterprise value to EBITDA ratio of IO Biotech, Inc. – OTC:IOBTQ - TradingView
Total debt per share of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Price to sales ratio of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Net margin % of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Quick ratio of IO Biotech, Inc. – OTC:IOBTQ - TradingView
Enterprise value of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
EBIT per share of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Cash from investing activities of IO Biotech, Inc. – OTC:IOBTQ - TradingView
Free cash flow per share of IO Biotech, Inc. – OTC:IOBTQ - TradingView — Track All Markets
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):